By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TrovaGene, Inc. 

420 Lexington Avenue
Suite 170
New York  New York  10170  U.S.A.
Phone: n/a Fax: n/a



Company News
TrovaGene, Inc.'s Urine-Based HPV Assay To Be Featured In Presentation At The 13th Annual Cervical Cancer Conference And HPV Consortium In Beijing 4/23/2015 11:25:02 AM
Poster Presentations At 2015 AACR Annual Meeting To Highlight Clinical Utilities And Advantages Of TrovaGene, Inc.'s ctDNA Precision Cancer Monitoring Platform 4/21/2015 2:10:54 PM
TrovaGene, Inc.'s Urinary ctDNA Assay Outperforms Tissue Biopsy In Clinical Study For The Detection Of EGFR T790M Mutations In Metastatic Lung Cancer Patients 4/17/2015 10:33:11 AM
TrovaGene, Inc. Reports Fourth Quarter And Full Year 2014 Financial Results 3/13/2015 7:46:47 AM
TrovaGene, Inc. Schedules Release Of Fourth Quarter And Year End 2014 Financial Results And Investor Conference Call 2/27/2015 7:18:49 AM
TrovaGene, Inc. Announces Closing Of Public Offering Of Common Stock 2/11/2015 10:50:00 AM
TrovaGene, Inc. To Present At Leerink Global Healthcare Conference 2/10/2015 11:57:03 AM
Clinical Results Demonstrate High Sensitivity Of TrovaGene, Inc.'s Urine-Based HPV Assay For The Detection Of High Risk HPV And Pre-Cancerous Cervical Lesions 2/9/2015 10:03:03 AM
TrovaGene, Inc. Announces Pricing Of Public Offering Of Common Stock 2/6/2015 7:36:43 AM
TrovaGene, Inc.'s Chief Scientific Officer To Present Precision Cancer Monitoring (SM) Platform Overview At The Personalized Medicine World Conference 1/26/2015 11:04:41 AM